Establishment of Bovine Trophoblast Stem-Like Cells from In Vitro - Produced Blastocyst-Stage Embryos Using Two Inhibitors

Authors:

Abstract
The trophoblast (TR) is the first to differentiate during mammalian embryogenesis and play a pivotal role in the development of the placenta. We used a dual inhibitor system (PD0325901 and CHIR99021) with mixed feeders to successfully obtain bovine trophoblast stem-like (bTS) cells, which were similar in phenotype to mouse trophoblast stem cells (TSCs). The bTS cells that were generated using this system continually proliferated, displayed a normal diploid karyotype, and had no signs of altered morphology or differentiation even after 150 passages. These cells exhibited alkaline phosphatase (AP) activity and expressed pluripotency markers, such as OCT4 , NANOG , SOX2 , SSEA-1 , SSEA-4 , TRA-1-60 , and TRA-1-81 , and TR lineage markers such as CDX2 , as determined by both immunofluorescence and reverse transcription-polymerase chain reaction (RT-PCR). Additionally, these cells generated dome-like structures, formed teratomas when injected into NOD-SCID mice, and differentiated into placenta TR cells in vitro. The microarray analysis of bTS cells showed high expression levels of many TR markers, such as TEAD4 , EOMES , GATA3 , ETS2 , TFAP2A , ELF5 , SMARCA4 ( BRG1 ), CDH3 , MASH2 , HSD17B1 , CYP11A1 , PPARG , ID2 , GCM1 , HAND1 , TDK , PAG , IFN-τ , and THAP11 . The expression of many pluripotency markers, such as OCT4 , SOX2 , NANOG , and GDF3 , was lower in bTS cells compared with in vitro-produced blastocysts; however, compared with bovine fetal fibroblasts, the expression of these pluripotency markers was elevated in bTS cells. The DNA methylation status of the promoter regions of OCT4 , NANOG , and SOX2 was investigated, which were significantly higher in bTS cells ( OCT4 23.90%, NANOG 74.40%, and SOX2 8.50%) compared with blastocysts ( OCT4 8.90%, NANOG 34.4%, and SOX2 3.80%). In contrast, two promoter regions of CDX2 were hypomethylated in bTS cells (13.80% and 3.90%) compared with blastocysts (18.80% and 9.10%). The TSC lines that were established in this study may be used either for basic research that is focused on peri-implantation and placenta development or as donor cells for transgenic animal production.